Mutations in PINK1 and Parkin/PRKN cause the degeneration of dopaminergic neurons in familial forms of Parkinson's disease but the precise pathogenic mechanisms are unknown. The PINK1/Parkin pathway has been described to play a central role in mitochondrial homeostasis by signaling the targeted destruction of damaged mitochondria, however, how disrupting this process leads to neuronal death until recently was unclear. An elegant study in mice revealed that the loss of Pink1 or Prkn coupled with an additional mitochondrial stress resulted in the aberrant activation of the innate immune signaling, mediated via the cGAS/STING pathway, causing degeneration of dopaminergic neurons and motor impairment. Genetic knockout of Sting was sufficient to completely prevent neurodegeneration and accompanying motor deficits. To determine whether Sting plays a conserved role in Pink1/parkin related pathology, we tested for genetic interactions between Sting and Pink1/parkin in Drosophila. Surprisingly, we found that loss of Sting, or its downstream effector Relish, was insufficient to suppress the behavioral deficits or mitochondria disruption in the Pink1/parkin mutants. Thus, we conclude that phenotypes associated with loss of Pink1/parkin are not universally due to aberrant activation of the STING pathway.
observed in Pink1 B9 flies. Taken together, these results indicate that Sting does not contribute to the neuromuscular phenotypes observed in Pink1/parkin mutants.
Considering that loss of STING in mouse completely abrogated the Pink1/Prkn-associated neurodegeneration and motor phenotypes provoked by additional mitochondrial stresses, we were surprised by the lack of suppression of Pink1/parkin phenotypes in flies. Therefore, to further interrogate the potential contribution of this pathway to Pink1/parkin pathology, we also analyzed a downstream effector of the Sting-IMD pathway, the transcription factor Relish (Rel). While RNAi knockdown using two previously characterized transgenes 11,13 elicited modest effect on climbing, Rel mutants (Rel E20 ) displayed a strong locomotor defect (Fig. 4A ). However, analysis of flight muscles in these mutants did not reveal any major disruption of mitochondrial integrity (Fig. 4B ).
Similar to the Sting manipulations, RNAi knockdown of Rel did not modify the climbing deficit of parkin or Pink1 mutants ( Fig. 5A ), nor did it noticeably affect the mitochondrial integrity in flight muscles ( Fig. 5B ). Indeed, in contrast to expectation, genetic loss of Rel enhanced the Pink1 locomotor defect (Fig. 5A ), although the mitochondrial integrity was not noticeably worsened in Rel E20 ;Pink1 B9 flies (Fig. 5B) .
In a final effort to assess whether the Drosophila Pink1/parkin-Sting axis acts in an analogous fashion to mice, we sought to recapitulate the conditions assessed by Sliter et al. 10 and test the role of Sting when an additional mitochondrial stress is combined with parkin loss-of-function. To do this, we used our previously established mtDNA mutator model (mito-APOBEC1), which generates high levels of deleterious mtDNA mutations in somatic tissues, disrupting mitochondrial function and causing motor defects and shortened lifespan 20 . Notably, the loss of parkin or Sting did not exacerbate the impact of mito-APOBEC1 alone on locomotor function ( Fig. 6 ). Furthermore, the combination of the mtDNA mutator in a parkin;Sting double mutant background, in stark contrast to the results in mice 10 , enhanced the climbing deficit ( Fig. 6 ).
Thus, together the above data suggest that the Sting pathway, although proposed to be mediating motor and neurodegenerative defects in Prkn -/mice, do not similarly contribute to the neuromuscular defects observed in Pink1/parkin mutant flies.
Discussion
Understanding the pathogenic mechanisms by which loss of function mutations in PINK1 and Parkin lead to neurodegeneration in Parkinson's disease is central to defining better disease-modifying therapies. While tremendous advances have been made in uncovering the molecular mechanisms of PINK1/Parkin function in vitro and in cell culture models, understanding the consequences of this dysfunction on neuronal demise must be studied in vivo, in the complex milieu of organismal biology.
This has been severely hampered by the lack of robust phenotypes in Pink1/Prkn knockout mice. In provoked an aberrant innate immune response mediated by the STING pathway, suggesting that the systemic inflammatory response ultimately caused the dopaminergic neurodegeneration and motor deficits. Indeed, genetic loss of STING was sufficient to completely prevent the inflammation, motor defect and neurodegeneration in the Prkn −/− ;mutator mice. These findings established the STING pathway and, more broadly, aberrant innate immune signaling, as a pathogenic cause and a highly attractive therapeutic target. Moreover, additional work has also implicated Pink1/Prkn mutations in inducing aberrant inflammation, albeit via adaptive immunity 22 . However, while the PINK1/Parkin pathway is clearly an ancient mechanism regulating mitochondrial quality control, our data indicate that Sting does not appear to be a fundamental, conserved feature of PINK1/Parkin biology.
The question arises why loss of Sting does not suppress Pink1/parkin phenotypes in flies when it is capable of completely preventing pathology in mice? At this stage, the answer is unknown and rather puzzling given that innate immune signaling is dysregulated in parkin mutants 15 , and Sting performs an analogous function in flies as it does in vertebrates 11 . One possibility is that the aberrant innate immune activation observed in parkin mutant flies is not mediated by the presence of cytosolic kindly provided as follows: Sting ΔRG5 from A. Goodman 11 , Pink1 B9 mutants from J. Chung 18 , and the park 25 mutants and UAS-mito-APOBEC1 have been described previously 17, 20 . All experiments were conducted using male flies.
Locomotor assays
The startle induced negative geotaxis (climbing) assay was performed using a counter-current apparatus. Briefly, 20-23 males were placed into the first chamber, tapped to the bottom, and given 10 s to climb a 10 cm distance. This procedure was repeated five times (five chambers), and the number of flies that has remained into each chamber counted. The weighted performance of several group of flies for each genotype was normalized to the maximum possible score and expressed as Climbing index 17 .
Immunohistochemistry and sample preparation
For immunostaining, adult flight muscles were dissected in PBS and fixed in 4% formaldehyde (pH 7.0) for 30 min, permeabilized in 0.3% Triton X-100 for 30 min, and blocked with 0.3% Triton X-100 plus 1% bovine serum albumin in PBS for 1 h at RT. Tissues were incubated with ATP5A antibody (Abcam Cat# ab14748, RRID:AB_301447; 1:500), diluted in 0.3% Triton X-100 plus 1% bovine serum albumin in PBS overnight at 4 o C, then rinsed 3 times 10 min with 0.3% Triton X-100 in PBS, and incubated with the appropriate fluorescent secondary antibodies overnight at 4 o C. The tissues were washed 2 times in PBS and mounted on slides using Prolong Diamond Antifade mounting medium (Thermo Fischer Scientific).
Microscopy
Fluorescence imaging was conducted using a Zeiss LSM 880 confocal microscope (Carl Zeiss MicroImaging) equipped with Nikon Plan-Apochromat 100x/1.4 NA oil immersion objectives. Images were prepared using Fiji software (Fiji, RRID:SCR_002285). For thoracic indentations, images were acquired using a Leica DFC490 camera mounted on a Leica MZ6 stereomicroscope.
Statistical analysis
For behavioral analyses, Kruskal-Wallis non-parametric test with Dunn's post-hoc correction for multiple comparisons was used. Analyses were performed using GraphPad Prism 8 software (RRID:SCR_002798).
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